{
    "Trade/Device Name(s)": [
        "cobas 8000 ISE Indirect Na, K, Cl for Gen. 2"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K140373",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123726",
        "K100853",
        "K132418",
        "K053165"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ"
    ],
    "Summary Letter Date": "May 22, 2014",
    "Summary Letter Received Date": "May 12, 2014",
    "Submission Date": "May 8, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1665",
        "21 CFR 862.1600",
        "21 CFR 862.1170"
    ],
    "Regulation Name(s)": [
        "Sodium test system",
        "Potassium test system",
        "Chloride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Plastic bottles closed via screw caps"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas 8000 ISE module",
        "cobas 8000 modular analyzer series",
        "Roche/Hitachi cobas c system"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode (ISE)",
        "Potentiometry"
    ],
    "Methodologies": [
        "Electrochemical ion measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for cobas 8000 ISE module calibration change and measuring range extension for sodium, potassium, and chloride in serum, plasma, and urine",
    "Indications for Use Summary": "Quantitative in vitro determination of sodium, potassium, and chloride in serum, plasma, and urine using ion-selective electrodes to aid diagnosis and treatment of electrolyte imbalance",
    "fda_folder": "Clinical Chemistry"
}